Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Deep brain stimulation devices industry 3600 synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Application trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 Deep Brain Stimulation Devices Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 – 2030 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing demand for minimally invasive surgery in developed countries
3.3.1.2 Rising prevalence of neurological disorders globally
3.3.1.3 Technological advancements in deep brain stimulation devices
3.3.1.4 Increasing number of elderly patients with neurological disorders
3.3.2 Restraints
3.3.2.1 Complications associated with deep brain stimulation
3.3.2.2 Lack of skilled healthcare practitioners
3.4 Growth potential analysis
3.4.1 By application
3.4.2 By end-use
3.5 COVID-19 impact analysis
3.6 Porter's analysis
3.7 Competitive landscape, 2021
3.8 PESTEL analysis
Chapter 4 Deep Brain Stimulation Devices, By Application
4.1 Key segment trends
4.2 Parkinson's disease
4.2.1 Market size, by region, 2017-2030 (USD Million)
4.3 Epilepsy
4.3.1 Market size, by region, 2017-2030 (USD Million)
4.4 Essential tremor
4.4.1 Market size, by region, 2017-2030 (USD Million)
4.5 Obsessive-compulsive disorder
4.5.1 Market size, by region, 2017-2030 (USD Million)
4.6 Dystonia
4.6.1 Market size, by region, 2017-2030 (USD Million)
4.7 Pain management
4.7.1 Market size, by region, 2017-2030 (USD Million)
4.8 Others
4.8.1 Market size, by region, 2017-2030 (USD Million)
Chapter 5 Deep Brain Stimulation Devices, By End-use
5.1 Key segment trends
5.2 Hospitals
5.2.1 Market size, by region, 2017-2030 (USD Million)
5.3 Ambulatory surgical centers
5.3.1 Market size, by region, 2017-2030 (USD Million)
5.4 Others
5.4.1 Market size, by region, 2017-2030 (USD Million)
Chapter 6 Deep Brain Stimulation Devices, By Region
6.1 Key regional trends
6.2 North America
6.2.1 Market size, by country, 2017-2030 (USD Million)
6.2.2 Market size, by application, 2017-2030 (USD Million)
6.2.3 Market size, by end-use, 2017-2030 (USD Million)
6.2.4 U.S.
6.2.4.1 Market size, by application, 2017-2030 (USD Million)
6.2.4.2 Market size, by end-use, 2017-2030 (USD Million)
6.2.5 Canada
6.2.5.1 Market size, by application, 2017-2030 (USD Million)
6.2.5.2 Market size, by end-use, 2017-2030 (USD Million)
6.3 Europe
6.3.1 Market size, by country, 2017-2030 (USD Million)
6.3.2 Market size, by application, 2017-2030 (USD Million)
6.3.3 Market size, by end-use, 2017-2030 (USD Million)
6.3.4 Germany
6.3.4.1 Market size, by application, 2017-2030 (USD Million)
6.3.4.2 Market size, by end-use, 2017-2030 (USD Million)
6.3.5 UK
6.3.5.1 Market size, by application, 2017-2030 (USD Million)
6.3.5.2 Market size, by end-use, 2017-2030 (USD Million)
6.3.6 France
6.3.6.1 Market size, by application, 2017-2030 (USD Million)
6.3.6.2 Market size, by end-use, 2017-2030 (USD Million)
6.3.7 Italy
6.3.7.1 Market size, by application, 2017-2030 (USD Million)
6.3.7.2 Market size, by end-use, 2017-2030 (USD Million)
6.3.8 Spain
6.3.8.1 Market size, by application, 2017-2030 (USD Million)
6.3.8.2 Market size, by end-use, 2017-2030 (USD Million)
6.4 Asia Pacific
6.4.1 Market size, by country, 2017-2030 (USD Million)
6.4.2 Market size, by application, 2017-2030 (USD Million)
6.4.3 Market size, by end-use, 2017-2030 (USD Million)
6.4.4 Japan
6.4.4.1 Market size, by application, 2017-2030 (USD Million)
6.4.4.2 Market size, by end-use, 2017-2030 (USD Million)
6.4.5 China
6.4.5.1 Market size, by application, 2017-2030 (USD Million)
6.4.5.2 Market size, by end-use, 2017-2030 (USD Million)
6.4.6 India
6.4.6.1 Market size, by application, 2017-2030 (USD Million)
6.4.6.2 Market size, by end-use, 2017-2030 (USD Million)
6.4.7 Australia
6.4.7.1 Market size, by application, 2017-2030 (USD Million)
6.4.7.2 Market size, by end-use, 2017-2030 (USD Million)
6.5 Latin America
6.5.1 Market size, by country, 2017-2030 (USD Million)
6.5.2 Market size, by application, 2017-2030 (USD Million)
6.5.3 Market size, by end-use, 2017-2030 (USD Million)
6.5.4 Brazil
6.5.4.1 Market size, by application, 2017-2030 (USD Million)
6.5.4.2 Market size, by end-use, 2017-2030 (USD Million)
6.5.5 Mexico
6.5.5.1 Market size, by application, 2017-2030 (USD Million)
6.5.5.2 Market size, by end-use, 2017-2030 (USD Million)
6.6 Middle East and Africa
6.6.1 Market size, by country, 2017-2030 (USD Million)
6.6.2 Market size, by application, 2017-2030 (USD Million)
6.6.3 Market size, by end-use, 2017-2030 (USD Million)
6.6.4 South Africa
6.6.4.1 Market size, by application, 2017-2030 (USD Million)
6.6.4.2 Market size, by end-use, 2017-2030 (USD Million)
6.6.5 Saudi Arabia
6.6.5.1 Market size, by application, 2017-2030 (USD Million)
6.6.5.2 Market size, by end-use, 2017-2030 (USD Million)
6.6.6 UAE
6.6.6.1 Market size, by application, 2017-2030 (USD Million)
6.6.6.2 Market size, by end-use, 2017-2030 (USD Million)
Chapter 7 Company Profiles
7.1 Strategy dashboard, 2021
7.2 Abbott
7.2.1 Financial data
7.2.2 Product landscape
7.2.3 Strategic outlook
7.2.4 SWOT analysis
7.3 Boston Scientific
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 SWOT analysis
7.4 Medtronic
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.4.5 SWOT analysis
7.5 Beijing PINS Medical Co. Ltd
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 SWOT analysis
7.6 SceneRay Co., Ltd.
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.6.5 SWOT analysis
